ENDOLUCINBETA

This brand name is authorized in Austria, Croatia, Estonia, France, Ireland, Italy, Lithuania, Poland.

Active ingredients

The drug ENDOLUCINBETA contains one active pharmaceutical ingredient (API):

1
UNII 1U477369SN - LUTETIUM CHLORIDE LU-177
 
Read more about Lutetium ¹⁷⁷Lu chloride

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
V10XX Various therapeutic radiopharmaceuticals V Various → V10 Therapeutic radiopharmaceuticals → V10X Other therapeutic radiopharmaceuticals
Discover more medicines within V10XX

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1725780, 1725791
FR Base de données publique des médicaments 61773428
IT Agenzia del Farmaco 044953014, 044953026
LT Valstybinė vaistų kontrolės tarnyba 1080756, 1080757
PL Rejestru Produktów Leczniczych 100382978

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈